These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 22611059)

  • 1. The promise of immunisation against rotavirus.
    Marlow RD; Finn A
    Arch Dis Child; 2012 Aug; 97(8):736-40. PubMed ID: 22611059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rotavirus vaccines: targeting the developing world.
    Glass RI; Bresee JS; Turcios R; Fischer TK; Parashar UD; Steele AD
    J Infect Dis; 2005 Sep; 192 Suppl 1():S160-6. PubMed ID: 16088799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011-2030.
    Atherly DE; Lewis KD; Tate J; Parashar UD; Rheingans RD
    Vaccine; 2012 Apr; 30 Suppl 1():A7-14. PubMed ID: 22520139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health economics of rotavirus immunization in Vietnam: potentials for favorable cost-effectiveness in developing countries.
    Tu HA; Rozenbaum MH; Coyte PC; Li SC; Woerdenbag HJ; Postma MJ
    Vaccine; 2012 Feb; 30(8):1521-8. PubMed ID: 22119590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating the costs of implementing the rotavirus vaccine in the national immunisation programme: the case of Malawi.
    Madsen LB; Ustrup M; Hansen KS; Nyasulu PS; Bygbjerg IC; Konradsen F
    Trop Med Int Health; 2014 Feb; 19(2):177-85. PubMed ID: 24314006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remaining issues and challenges for rotavirus vaccine in preventing global childhood diarrheal morbidity and mortality.
    Tate JE; Patel MM; Cortese MM; Lopman BA; Gentsch JR; Fleming J; Steele AD; Parashar UD
    Expert Rev Vaccines; 2012 Feb; 11(2):211-20. PubMed ID: 22309669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic analysis for evidence-based policy-making on a national immunization program: a case of rotavirus vaccine in Thailand.
    Muangchana C; Riewpaiboon A; Jiamsiri S; Thamapornpilas P; Warinsatian P
    Vaccine; 2012 Apr; 30(18):2839-47. PubMed ID: 22387220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rotavirus vaccines: entering a new stage of deployment.
    Nakagomi O; Cunliffe NA
    Curr Opin Infect Dis; 2007 Oct; 20(5):501-7. PubMed ID: 17762784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on Rotarix: an oral human rotavirus vaccine.
    O'Ryan M; Linhares AC
    Expert Rev Vaccines; 2009 Dec; 8(12):1627-41. PubMed ID: 19943758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rotavirus vaccines in developed countries.
    Buttery JP; Kirkwood C
    Curr Opin Infect Dis; 2007 Jun; 20(3):253-8. PubMed ID: 17471034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential impact and cost-effectiveness analysis of rotavirus vaccination of children in Israel.
    Chodick G; Waisbourd-Zinman O; Shalev V; Kokia E; Rabinovich M; Ashkenazi S
    Eur J Public Health; 2009 Jun; 19(3):254-9. PubMed ID: 19221026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of universal rotavirus vaccination in reducing rotavirus gastroenteritis in Ireland.
    Tilson L; Jit M; Schmitz S; Walsh C; Garvey P; McKeown P; Barry M
    Vaccine; 2011 Oct; 29(43):7463-73. PubMed ID: 21821085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Public health. Progress toward rotavirus vaccines.
    Parashar UD; Glass RI
    Science; 2006 May; 312(5775):851-2. PubMed ID: 16690845
    [No Abstract]   [Full Text] [Related]  

  • 14. Cost and cost-effectiveness of childhood vaccination against rotavirus in France.
    Melliez H; Levybruhl D; Boelle PY; Dervaux B; Baron S; Yazdanpanah Y
    Vaccine; 2008 Jan; 26(5):706-15. PubMed ID: 18166250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic evaluations of rotavirus immunization for developing countries: a review of the literature.
    Tu HA; Woerdenbag HJ; Kane S; Rozenbaum MH; Li SC; Postma MJ
    Expert Rev Vaccines; 2011 Jul; 10(7):1037-51. PubMed ID: 21806398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress in the introduction of rotavirus vaccine--Latin America and the Caribbean, 2006-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Dec; 60(47):1611-4. PubMed ID: 22129995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rotarix in developing countries: paving the way for inclusion in national childhood immunization programs in Africa.
    Pawinski R; Debrus S; Delem A; Smolenov I; Suryakiran PV; Han HH
    J Infect Dis; 2010 Sep; 202 Suppl():S80-6. PubMed ID: 20684722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam.
    Fischer TK; Anh DD; Antil L; Cat ND; Kilgore PE; Thiem VD; Rheingans R; Tho le H; Glass RI; Bresee JS
    J Infect Dis; 2005 Nov; 192(10):1720-6. PubMed ID: 16235169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rotavirus vaccines: safety, efficacy and public health impact.
    Gray J
    J Intern Med; 2011 Sep; 270(3):206-14. PubMed ID: 21668823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RotaTeq: Progress toward developing world access.
    Goveia MG; Nelson CB; Ciarlet M
    J Infect Dis; 2010 Sep; 202 Suppl():S87-92. PubMed ID: 20684723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.